Obermatt
See Similar Stocks →

Adicet Bio

NAQ:ACET · US0070022076
BiotechnologySmall

360° View

26
Price/Sales24
Price/Earnings45
Price/Book75
Dividend Yield1
Revenue Growth—
Profit Growth25
Capital Growth4
TSR 52w8
Leverage59
Liquidity5
Refinancing1
Combined6
Analyst Opinions100
Pro Holdings27
Opinion Changes95
Market Pulse47

Profile

CountryUSA
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Employees116
Websiteadicetbio.com
ISINUS0070022076
Last UpdateApr 2, 2026
Index & Theme
Chronic DiseasesStem Cell TherapyHematologyInflammationNephrologyImmunologyGeneticsOncologyBiopharmaBiotechnologyHealth CareMedical

Description

Adicet Bio, Inc. operates as a clinical stage biotechnology company that discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases cancer. The company's approach to activate, engineer, and manufacture allogeneic gamma de…

Analysis

Adicet Bio's 360° View rank of 26 places it below its peer average — better than 26% of its true peers.

It's lagging on growth (4) and reasonably valued (65). On safety it is highly leveraged (8), and the market shows strongly positive sentiment (95). Taken together, its Combined rank of 6 reads as among the weakest overall.

360° rank · history

1007550250
26
2026

All-time high

26

Jun 2026

All-time low

4

Mar 2026

Average rank

15

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
24
—
—
—
Price/Earnings
45
—
—
—
Price/Book
75
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
65
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Adicet Bio with its peers
Nektar
NAQ:NKTR
4
CountryUSA
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Rapport Therapeutics
NMQ:RAPP
13
CountryUSA
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Relmada Therapeutics
NAQ:RLMD
—
CountryUSA
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Omeros
NMQ:OMER
29
CountryUSA
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
AnaptysBio
NSQ:ANAB
44
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Harmony Biosciences Holdings
NMQ:HRMY
94
CountryUSA
IndustryPharmaceuticals
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →